Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140002/S032

MISAGO(TM) RX Self-expanding Peripheral Stent

Terumo Medical Corporation · Decision date Jul 16, 2026

FDA DECISIONP140002/S032

What did the FDA approve?

FDA records P140002/S032 as a supplement to PMA P140002, with the supplement type “Panel Track”. The recorded decision is approval, dated Jul 16, 2026.

FDA approval order statement

The Misago RX Self-expanding Peripheral Stent is indicated to improve the luminal diameter in patient with de novo, restenotic and/or occlusive atherosclerotic lesion(s) in the common and/or external iliac artery. The reference vessel diameters range from 4.0 mm to 9.0 mm and the lesion length is up to 120 mm.
Regulatory pathway
PMA supplement
Supplement type
Panel Track
Clinical specialty
Cardiovascular
Decision date
Jul 16, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P140002/S032
Regulatory pathway
PMA supplement
Product code
NIO
Decision code
APPR
Decision date
Jul 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Product code
NIO
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P140002/S029 · Related supplement

    MISAGO RX Self-expanding Peripheral Stent; R2P Misago RX Self-expanding Peripheral Stent System

  2. P140002/S030 · Related supplement

    MISAGO RX Self-expanding Peripheral Stent

  3. P140002/S031 · Related supplement

    MISAGO RX Self-expanding Peripheral Stent

  4. P140002/S032 received

    Application receipt date recorded by FDA.

  5. P140002/S033 · Related supplement

    MISAGO RX Self-expanding Peripheral Stent

  6. P140002/S032 · FDA decision

    Panel Track

Timeline entries are records held by MedtechLedger for P140002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140002

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA
Boston Scientific CorpPMA supplementAug 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Terumo Medical Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
950 Elkton Blvd., Hatagaya, 151-0072

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records